Prostate Cell News Volume 16.07 | Apr 25 2025

    0
    36







    2025-04-25 | PCN 16.07


    Prostate Cell News by STEMCELL Technologies
    Vol. 16.07 – 25 April, 2025
    TOP STORY

    PARP Inhibitor Response Is Enhanced in Prostate Cancer When XRCC1 Expression Is Reduced

    Researchers analyzed prostate cancer patients’ cohorts and found that XRCC1 expression varied widely, with many patients showing low XRCC1 expression.
    [NAR Cancer]

    Full Article
    Graphical Abstract
    PUBLICATIONSListed by the impact factor of the journal

    Prostate Cancer Exploits BRD9-Driven Metabolic Reprogramming to Shape the Aggressive Phenotype

    Scientists identified bromodomain-containing protein 9 (BRD9) as a metabolic checkpoint for reprogramming cell metabolism to support tumor growth and impart a castration-resistant phenotype under metabolic and oxidative stress.
    [Cell Death & Disease]

    Full Article

    SPOP Mutations Increase PARP Inhibitor Sensitivity via CK2/PIAS1/SPOP Axis in Prostate Cancer

    Investigators found profound genomic instability in prostate cancer (PCa) cells with speckle-type POZ protein (SPOP) gene mutations and confirmed the sensitivity of SPOP-mutated PCa cells to olaparib-induced apoptosis.
    [JCI Insight]

    Full ArticleGraphical Abstract

    ZIF-8/Doxorubicin Nanoparticles Camouflaged with Cucurbita-Derived Exosomes for Targeted Prostate Cancer Therapy

    Scientists designed a biomimetic nanocarrier composed of zeolitic imidazolate framework-8 (ZIF-8) encapsulating doxorubicin as the core and a shell of exosome-like nanoparticles derived from Cucurbita moschata. This design enhances safety and addresses some exosome limitations.
    [Journal of Materials Chemistry B]

    AbstractGraphical Abstract

    Valosin-Containing Protein (VCP/p97) Mediates Neuroendocrine Differentiation in Prostate Cancer Cells through Pim1 Signaling Inducing Autophagy

    Investigators explored the molecular mechanisms through which valosin-containing protein/p97 contributed to the progression of neuroendocrine prostate cancer.
    [The Prostate]

    Abstract

    Stachydrine Hydrochloride Induces Cell Senescence and Ferroptosis of Castration-Resistant Prostate Cancer

    Scientists explored the potential of stachydrine hydrochloride in addressing paclitaxel resistance within castration-resistant prostate cancer.
    [Naunyn-Schmiedebergs Archives of Pharmacology]

    Abstract
    Download these free lab templates to increase your efficiency as a life science researcher.
    REVIEWS

    The Role of Androgens and Global and Tissue-Specific Androgen Receptor Expression on Body Composition, Exercise Adaptation, and Performance

    The authors summarize the understood mechanisms of action of androgen receptor (AR) and its interactions with exercise, specifically on outcomes of body composition and muscle function, and the global- and tissue-specific role of AR in regulating skeletal muscle, adipose, and bone morphology.
    [Biology of Sex Differences]

    Full Article

    PSMA-Based Therapies and Novel Therapies in Advanced Prostate Cancer: The Now and the Future

    The future of mCRPC treatment likely lies in a personalized, multimodal approach that integrates PSMA-based RLTs, BiTEs, and complementary therapies at earlier disease stages.
    [Current Treatment Options In Oncology]

    Full Article
    INDUSTRY AND POLICY NEWS

    Cardiff Oncology Announces a Second Patent for the Treatment of mCRC for Bev-Naïve Patients

    Cardiff Oncology, Inc. recieved U.S. patent No. 12,263,173 covering the method of using onvansertib in combination with bevacizumab (bev) in any line of therapy for the treatment of metastatic colorectal cancer (mCRC) patients who have not previously been treated with bev.
    [Cardiff Oncology]

    Press Release
    FEATURED EVENT

    Infection: Pathogens, Hosts, and Microbiomes

    May 26-28, 2025
    Heidelberg, Germany & Online

    > See All Events

    JOB OPPORTUNITIES

    Studentship – Implantable Device for Treatment of Prostate Cancer

    Ulster University – Coleraine, Northern Ireland, United Kingdom

    Research Associate / Postdoctoral Position – Regenerative Medicine

    Technische Universität Dresden – Dresden, Germany

    Laboratory Research Assistant – Prostate Research

    Vancouver Prostate Centre – Vancouver, British Columbia, Canada

    Postdoctoral Research Fellow – Advanced Prostate Cancer

    Dana-Farber Cancer Institute – Boston, Massachusetts, United States

    Research Scholar/Postdoctoral Fellow – Prostate Cancer

    Macon & Joan Brock Virginia Health Sciences at Old Dominion University – Norfolk, Virginia, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2